These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21055937)

  • 1. Blockade of TNF in vivo using cV1q antibody reduces contractile dysfunction of skeletal muscle in response to eccentric exercise in dystrophic mdx and normal mice.
    Piers AT; Lavin T; Radley-Crabb HG; Bakker AJ; Grounds MD; Pinniger GJ
    Neuromuscul Disord; 2011 Feb; 21(2):132-41. PubMed ID: 21055937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced muscle necrosis and long-term benefits in dystrophic mdx mice after cV1q (blockade of TNF) treatment.
    Radley HG; Davies MJ; Grounds MD
    Neuromuscul Disord; 2008 Mar; 18(3):227-38. PubMed ID: 18207402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFalpha function with Etanercept in mdx mice.
    Hodgetts S; Radley H; Davies M; Grounds MD
    Neuromuscul Disord; 2006 Oct; 16(9-10):591-602. PubMed ID: 16935507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
    Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
    J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single 30 min treadmill exercise session is suitable for 'proof-of concept studies' in adult mdx mice: a comparison of the early consequences of two different treadmill protocols.
    Radley-Crabb H; Terrill J; Shavlakadze T; Tonkin J; Arthur P; Grounds M
    Neuromuscul Disord; 2012 Feb; 22(2):170-82. PubMed ID: 21835619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-TNFalpha (Remicade) therapy protects dystrophic skeletal muscle from necrosis.
    Grounds MD; Torrisi J
    FASEB J; 2004 Apr; 18(6):676-82. PubMed ID: 15054089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poloxamer 188 failed to prevent exercise-induced membrane breakdown in mdx skeletal muscle fibers.
    Quinlan JG; Wong BL; Niemeier RT; McCullough AS; Levin L; Emanuele M
    Neuromuscul Disord; 2006 Dec; 16(12):855-64. PubMed ID: 17118658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1.
    De Luca A; Pierno S; Liantonio A; Cetrone M; Camerino C; Fraysse B; Mirabella M; Servidei S; Rüegg UT; Conte Camerino D
    J Pharmacol Exp Ther; 2003 Jan; 304(1):453-63. PubMed ID: 12490622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cromolyn administration (to block mast cell degranulation) reduces necrosis of dystrophic muscle in mdx mice.
    Radley HG; Grounds MD
    Neurobiol Dis; 2006 Aug; 23(2):387-97. PubMed ID: 16798005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Streptomycin reduces stretch-induced membrane permeability in muscles from mdx mice.
    Whitehead NP; Streamer M; Lusambili LI; Sachs F; Allen DG
    Neuromuscul Disord; 2006 Dec; 16(12):845-54. PubMed ID: 17005404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventilatory dysfunction in mdx mice: impact of tumor necrosis factor-alpha deletion.
    Gosselin LE; Barkley JE; Spencer MJ; McCormick KM; Farkas GA
    Muscle Nerve; 2003 Sep; 28(3):336-43. PubMed ID: 12929194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The soy isoflavone genistein blunts nuclear factor kappa-B, MAPKs and TNF-α activation and ameliorates muscle function and morphology in mdx mice.
    Messina S; Bitto A; Aguennouz M; Vita GL; Polito F; Irrera N; Altavilla D; Marini H; Migliorato A; Squadrito F; Vita G
    Neuromuscul Disord; 2011 Aug; 21(8):579-89. PubMed ID: 21658942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice.
    Schertzer JD; Ryall JG; Lynch GS
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E499-505. PubMed ID: 16621899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Acetylcysteine treatment of dystrophic mdx mice results in protein thiol modifications and inhibition of exercise induced myofibre necrosis.
    Terrill JR; Radley-Crabb HG; Grounds MD; Arthur PG
    Neuromuscul Disord; 2012 May; 22(5):427-34. PubMed ID: 22206641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice.
    Messina S; Bitto A; Aguennouz M; Minutoli L; Monici MC; Altavilla D; Squadrito F; Vita G
    Exp Neurol; 2006 Mar; 198(1):234-41. PubMed ID: 16410003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted expression of insulin-like growth factor-I reduces early myofiber necrosis in dystrophic mdx mice.
    Shavlakadze T; White J; Hoh JF; Rosenthal N; Grounds MD
    Mol Ther; 2004 Nov; 10(5):829-43. PubMed ID: 15509501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The physiological effects of IGF-1 (class 1:Ea transgene) over-expression on exercise-induced damage and adaptation in dystrophic muscles of mdx mice.
    Ridgley JA; Pinniger GJ; Hamer PW; Grounds MD
    Pflugers Arch; 2009 Mar; 457(5):1121-32. PubMed ID: 18726613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of cross-talk between tumour necrosis factor and insulin-like growth factor-1 signalling in skeletal muscle.
    Grounds MD; Radley HG; Gebski BL; Bogoyevitch MA; Shavlakadze T
    Clin Exp Pharmacol Physiol; 2008 Jul; 35(7):846-51. PubMed ID: 18215180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weekly oral prednisolone improves survival and strength in male mdx mice.
    Keeling RM; Golumbek PT; Streif EM; Connolly AM
    Muscle Nerve; 2007 Jan; 35(1):43-8. PubMed ID: 16969833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy.
    Terrill JR; Pinniger GJ; Graves JA; Grounds MD; Arthur PG
    J Physiol; 2016 Jun; 594(11):3095-110. PubMed ID: 26659826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.